MedPath
HSA Approval

CREDANIL 25/100 TABLET

SIN10285P

CREDANIL 25/100 TABLET

CREDANIL 25/100 TABLET

October 14, 1998

GOLDPLUS UNIVERSAL PTE LTD

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD
Licence HolderGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

N04BA02

levodopa and decarboxylase inhibitor

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

REMEDICA LTD

Active Ingredients

CARBIDOPA MONOHYDRATE EQV CARBIDOPA

25 mg

Carbidopa

LEVODOPA

100 mg

Levodopa

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.